Latest news with #WELLHealthTechnologies'
Yahoo
22-04-2025
- Business
- Yahoo
Rainbows and Unicorns: WELL Health Technologies Corp. (TSE:WELL) Analysts Just Became A Lot More Optimistic
WELL Health Technologies Corp. (TSE:WELL) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Following the upgrade, the latest consensus from WELL Health Technologies' 13 analysts is for revenues of CA$1.4b in 2025, which would reflect a huge 49% improvement in sales compared to the last 12 months. Statutory earnings per share are supposed to decrease 7.2% to CA$0.12 in the same period. Prior to this update, the analysts had been forecasting revenues of CA$1.2b and earnings per share (EPS) of CA$0.069 in 2025. So we can see there's been a pretty clear increase in analyst sentiment in recent times, with both revenues and earnings per share receiving a decent lift in the latest estimates. View our latest analysis for WELL Health Technologies Despite these upgrades, the consensus price target fell 6.3% to CA$7.86, perhaps signalling that the uplift in performance is not expected to last. These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the WELL Health Technologies' past performance and to peers in the same industry. We can infer from the latest estimates that forecasts expect a continuation of WELL Health Technologies'historical trends, as the 49% annualised revenue growth to the end of 2025 is roughly in line with the 49% annual revenue growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 12% annually. So although WELL Health Technologies is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry. The biggest takeaway for us from these new estimates is that analysts upgraded their earnings per share estimates, with improved earnings power expected for this year. Fortunately, analysts also upgraded their revenue estimates, and our data indicates sales are expected to perform better than the wider market. A lower price target is not intuitively what we would expect from a company whose business prospects are improving - at least judging by these forecasts - but if the underlying fundamentals are strong, WELL Health Technologies could be one for the watch list. Still, the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for WELL Health Technologies going out to 2027, and you can see them free on our platform here.. Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
15-04-2025
- Business
- Yahoo
WELL Health Technologies (TSX:WELL) Sees Revenue Surge With 2025 Guidance Reaching A$1.40 Billion
WELL Health Technologies recently provided robust earnings and revenue guidance, projecting revenue between CAD 1.40 billion and CAD 1.45 billion for 2025. Their reported sales of CAD 920 million in 2024, up from CAD 776 million, signifies healthy growth in the healthcare technology sector. This was reflected in a 2% price rise over the past week, which aligns with broader market trends where the market gained 7%. The positive financial outlook and earnings forecast likely complemented the overall market momentum, which has been supported by upward trends in tech stocks amid easing U.S.-China trade tensions. We've identified 2 risks with WELL Health Technologies (at least 1 which is a bit concerning) and understanding the impact should be part of your investment process. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent robust earnings and revenue projections for WELL Health Technologies, forecasting CAD 1.40 billion to CAD 1.45 billion in revenue by 2025, could influence the company's strategic growth narrative, emphasizing consolidation and expansion within the healthcare technology sector. The anticipated revenue growth is likely to benefit from market momentum and easing trade tensions that have bolstered tech stocks. These optimistic forecasts may impact the company's earnings projections, despite analysts expecting a decline in profit margins to 3.1% from 7.7%. The company's emphasis on AI-driven tools and acquisitions could streamline operations, further supporting revenue growth but potentially causing profit margins to decline over time. Over the past five years, WELL Health Technologies has delivered a total shareholder return of 125.93%, reflecting significant long-term value creation. This return contrasts with the company's one-year performance, where it exceeded both the Canadian Market, up 7.4%, and the healthcare industry, which saw a 20.5% gain. The current share price of CAD 4.00 presents a substantial discount to the analyst consensus price target of CAD 8.39, suggesting a more than 50% potential upside if market conditions align with the analysts' expectations. Investors may need to consider how these projections align with their own analyses, especially given the expected decline in earnings growth over the next three years. Examine WELL Health Technologies' earnings growth report to understand how analysts expect it to perform. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:WELL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
